BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $47,530,000 | -7.3% | 314,412 | -10.6% | 0.02% | 0.0% |
| Q2 2022 | $51,272,000 | -32.8% | 351,877 | -45.3% | 0.02% | -20.7% |
| Q1 2022 | $76,280,000 | -52.0% | 643,336 | -44.3% | 0.03% | -48.2% |
| Q4 2021 | $159,078,000 | +6.4% | 1,154,328 | +7.3% | 0.06% | -5.1% |
| Q3 2021 | $149,444,000 | +10.0% | 1,075,834 | -23.2% | 0.06% | +7.3% |
| Q2 2021 | $135,904,000 | +36.5% | 1,399,920 | -3.9% | 0.06% | +25.0% |
| Q1 2021 | $99,556,000 | -3.6% | 1,456,559 | +20.9% | 0.04% | -10.2% |
| Q4 2020 | $103,298,000 | +9.6% | 1,205,204 | -16.8% | 0.05% | -3.9% |
| Q3 2020 | $94,210,000 | +5.8% | 1,449,164 | +18.9% | 0.05% | -1.9% |
| Q2 2020 | $89,087,000 | +72.7% | 1,218,528 | -19.6% | 0.05% | +40.5% |
| Q1 2020 | $51,583,000 | -42.2% | 1,515,810 | -7.5% | 0.04% | -27.5% |
| Q4 2019 | $89,238,000 | +11.9% | 1,639,190 | -14.2% | 0.05% | +2.0% |
| Q3 2019 | $79,734,000 | +25.0% | 1,911,181 | +31.2% | 0.05% | +28.2% |
| Q2 2019 | $63,807,000 | -15.3% | 1,457,091 | -0.4% | 0.04% | -20.4% |
| Q1 2019 | $75,306,000 | +46.4% | 1,463,109 | +5.2% | 0.05% | +28.9% |
| Q4 2018 | $51,440,000 | -13.6% | 1,391,019 | -12.2% | 0.04% | -2.6% |
| Q3 2018 | $59,516,000 | -16.4% | 1,584,982 | -12.0% | 0.04% | -22.0% |
| Q2 2018 | $71,191,000 | +89.5% | 1,801,380 | +23.5% | 0.05% | +85.2% |
| Q1 2018 | $37,559,000 | -12.9% | 1,458,027 | -8.7% | 0.03% | -12.9% |
| Q4 2017 | $43,107,000 | +33.4% | 1,597,756 | +84.9% | 0.03% | +29.2% |
| Q3 2017 | $32,305,000 | +196.9% | 864,230 | +98.6% | 0.02% | +200.0% |
| Q2 2017 | $10,880,000 | – | 435,209 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |